0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nasal Spray Influenza Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5E8891
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Nasal Spray Influenza Vaccine Market Outlook 2022
BUY CHAPTERS

Global Nasal Spray Influenza Vaccine Market Research Report 2025

Code: QYRE-Auto-5E8891
Report
July 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nasal Spray Influenza Vaccine Market Size

The global market for Nasal Spray Influenza Vaccine was valued at US$ 597 million in the year 2024 and is projected to reach a revised size of US$ 892 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Nasal Spray Influenza Vaccine Market

Nasal Spray Influenza Vaccine Market

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nasal Spray Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Spray Influenza Vaccine.
The Nasal Spray Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nasal Spray Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nasal Spray Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nasal Spray Influenza Vaccine Market Report

Report Metric Details
Report Name Nasal Spray Influenza Vaccine Market
Accounted market size in year US$ 597 million
Forecasted market size in 2031 US$ 892 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Cipla, BCHT
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nasal Spray Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nasal Spray Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nasal Spray Influenza Vaccine Market growing?

Ans: The Nasal Spray Influenza Vaccine Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Nasal Spray Influenza Vaccine Market size in 2031?

Ans: The Nasal Spray Influenza Vaccine Market size in 2031 will be US$ 892 million.

Who are the main players in the Nasal Spray Influenza Vaccine Market report?

Ans: The main players in the Nasal Spray Influenza Vaccine Market are AstraZeneca, Cipla, BCHT

What are the Application segmentation covered in the Nasal Spray Influenza Vaccine Market report?

Ans: The Applications covered in the Nasal Spray Influenza Vaccine Market report are Child, Adult

What are the Type segmentation covered in the Nasal Spray Influenza Vaccine Market report?

Ans: The Types covered in the Nasal Spray Influenza Vaccine Market report are Inactive, Live

Recommended Reports

Influenza Vaccines

Nasal Spray Therapies

Allergy & Rhinitis

1 Nasal Spray Influenza Vaccine Market Overview
1.1 Product Definition
1.2 Nasal Spray Influenza Vaccine by Type
1.2.1 Global Nasal Spray Influenza Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inactive
1.2.3 Live
1.3 Nasal Spray Influenza Vaccine by Application
1.3.1 Global Nasal Spray Influenza Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Child
1.3.3 Adult
1.4 Global Nasal Spray Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Nasal Spray Influenza Vaccine Revenue 2020-2031
1.4.2 Global Nasal Spray Influenza Vaccine Sales 2020-2031
1.4.3 Global Nasal Spray Influenza Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nasal Spray Influenza Vaccine Market Competition by Manufacturers
2.1 Global Nasal Spray Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nasal Spray Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nasal Spray Influenza Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nasal Spray Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nasal Spray Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nasal Spray Influenza Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Nasal Spray Influenza Vaccine, Date of Enter into This Industry
2.8 Global Nasal Spray Influenza Vaccine Market Competitive Situation and Trends
2.8.1 Global Nasal Spray Influenza Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nasal Spray Influenza Vaccine Players Market Share by Revenue
2.8.3 Global Nasal Spray Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nasal Spray Influenza Vaccine Market Scenario by Region
3.1 Global Nasal Spray Influenza Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nasal Spray Influenza Vaccine Sales by Region: 2020-2031
3.2.1 Global Nasal Spray Influenza Vaccine Sales by Region: 2020-2025
3.2.2 Global Nasal Spray Influenza Vaccine Sales by Region: 2026-2031
3.3 Global Nasal Spray Influenza Vaccine Revenue by Region: 2020-2031
3.3.1 Global Nasal Spray Influenza Vaccine Revenue by Region: 2020-2025
3.3.2 Global Nasal Spray Influenza Vaccine Revenue by Region: 2026-2031
3.4 North America Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Nasal Spray Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nasal Spray Influenza Vaccine Sales by Country (2020-2031)
3.4.3 North America Nasal Spray Influenza Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Nasal Spray Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nasal Spray Influenza Vaccine Sales by Country (2020-2031)
3.5.3 Europe Nasal Spray Influenza Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nasal Spray Influenza Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Nasal Spray Influenza Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Nasal Spray Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nasal Spray Influenza Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Nasal Spray Influenza Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nasal Spray Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nasal Spray Influenza Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nasal Spray Influenza Vaccine Sales by Type (2020-2031)
4.1.1 Global Nasal Spray Influenza Vaccine Sales by Type (2020-2025)
4.1.2 Global Nasal Spray Influenza Vaccine Sales by Type (2026-2031)
4.1.3 Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Nasal Spray Influenza Vaccine Revenue by Type (2020-2031)
4.2.1 Global Nasal Spray Influenza Vaccine Revenue by Type (2020-2025)
4.2.2 Global Nasal Spray Influenza Vaccine Revenue by Type (2026-2031)
4.2.3 Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Nasal Spray Influenza Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nasal Spray Influenza Vaccine Sales by Application (2020-2031)
5.1.1 Global Nasal Spray Influenza Vaccine Sales by Application (2020-2025)
5.1.2 Global Nasal Spray Influenza Vaccine Sales by Application (2026-2031)
5.1.3 Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Nasal Spray Influenza Vaccine Revenue by Application (2020-2031)
5.2.1 Global Nasal Spray Influenza Vaccine Revenue by Application (2020-2025)
5.2.2 Global Nasal Spray Influenza Vaccine Revenue by Application (2026-2031)
5.2.3 Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Nasal Spray Influenza Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Nasal Spray Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Nasal Spray Influenza Vaccine Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Company Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Nasal Spray Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cipla Nasal Spray Influenza Vaccine Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 BCHT
6.3.1 BCHT Company Information
6.3.2 BCHT Description and Business Overview
6.3.3 BCHT Nasal Spray Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BCHT Nasal Spray Influenza Vaccine Product Portfolio
6.3.5 BCHT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nasal Spray Influenza Vaccine Industry Chain Analysis
7.2 Nasal Spray Influenza Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nasal Spray Influenza Vaccine Production Mode & Process Analysis
7.4 Nasal Spray Influenza Vaccine Sales and Marketing
7.4.1 Nasal Spray Influenza Vaccine Sales Channels
7.4.2 Nasal Spray Influenza Vaccine Distributors
7.5 Nasal Spray Influenza Vaccine Customer Analysis
8 Nasal Spray Influenza Vaccine Market Dynamics
8.1 Nasal Spray Influenza Vaccine Industry Trends
8.2 Nasal Spray Influenza Vaccine Market Drivers
8.3 Nasal Spray Influenza Vaccine Market Challenges
8.4 Nasal Spray Influenza Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nasal Spray Influenza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nasal Spray Influenza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nasal Spray Influenza Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nasal Spray Influenza Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nasal Spray Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nasal Spray Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nasal Spray Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nasal Spray Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nasal Spray Influenza Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nasal Spray Influenza Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Nasal Spray Influenza Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nasal Spray Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Spray Influenza Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nasal Spray Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nasal Spray Influenza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Nasal Spray Influenza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Nasal Spray Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nasal Spray Influenza Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Nasal Spray Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nasal Spray Influenza Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Nasal Spray Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nasal Spray Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nasal Spray Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nasal Spray Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nasal Spray Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nasal Spray Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nasal Spray Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nasal Spray Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nasal Spray Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nasal Spray Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nasal Spray Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nasal Spray Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nasal Spray Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nasal Spray Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nasal Spray Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nasal Spray Influenza Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Nasal Spray Influenza Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nasal Spray Influenza Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Nasal Spray Influenza Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Nasal Spray Influenza Vaccine Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Cipla Company Information
 Table 76. Cipla Description and Business Overview
 Table 77. Cipla Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Cipla Nasal Spray Influenza Vaccine Product
 Table 79. Cipla Recent Developments/Updates
 Table 80. BCHT Company Information
 Table 81. BCHT Description and Business Overview
 Table 82. BCHT Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BCHT Nasal Spray Influenza Vaccine Product
 Table 84. BCHT Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Nasal Spray Influenza Vaccine Distributors List
 Table 88. Nasal Spray Influenza Vaccine Customers List
 Table 89. Nasal Spray Influenza Vaccine Market Trends
 Table 90. Nasal Spray Influenza Vaccine Market Drivers
 Table 91. Nasal Spray Influenza Vaccine Market Challenges
 Table 92. Nasal Spray Influenza Vaccine Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nasal Spray Influenza Vaccine
 Figure 2. Global Nasal Spray Influenza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nasal Spray Influenza Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Inactive Product Picture
 Figure 5. Live Product Picture
 Figure 6. Global Nasal Spray Influenza Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Nasal Spray Influenza Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Child
 Figure 9. Adult
 Figure 10. Global Nasal Spray Influenza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Nasal Spray Influenza Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Nasal Spray Influenza Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Nasal Spray Influenza Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Nasal Spray Influenza Vaccine Report Years Considered
 Figure 15. Nasal Spray Influenza Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Nasal Spray Influenza Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Nasal Spray Influenza Vaccine Players: Market Share by Revenue in Nasal Spray Influenza Vaccine in 2024
 Figure 18. Nasal Spray Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Nasal Spray Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Nasal Spray Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Nasal Spray Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Nasal Spray Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Nasal Spray Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Nasal Spray Influenza Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Nasal Spray Influenza Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Nasal Spray Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Nasal Spray Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Nasal Spray Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Nasal Spray Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Nasal Spray Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Nasal Spray Influenza Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Nasal Spray Influenza Vaccine by Type (2020-2031)
 Figure 54. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Nasal Spray Influenza Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Nasal Spray Influenza Vaccine by Application (2020-2031)
 Figure 57. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Nasal Spray Influenza Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India